Gara Jalqabaatti › Saree Oljoo › Distaarikii Koloombiyaa › Washington
Qorannoo klinikaalii Saree Oljoo Washington, DC keessatti
Qorannoo 46 Saree Oljoo f Washington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
Namoota walitti qabaa jiraQorannoo ilaalaa
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
The Vanguard Study: Testing a New Way to Screen for Cancer
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Georgetown University Medical Center, Washington D.C.
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Namoota walitti qabaa jiraSadarkaa 2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Namoota walitti qabaa jiraQorannoo ilaalaa
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Maryland Oncology Hematology P A, Silver Spring · Miili 7 fagaatti
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
Genomic Services Research Program
Namoota walitti qabaa jiraQorannoo ilaalaa
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Older Breast Cancer Patients: Risk for Cognitive Decline
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Georgetown University, Washington D.C.
Collection of Blood From Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Namoota walitti qabaa jiraSadarkaa 2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Namoota walitti qabaa jiraSadarkaa 3
- Holy Cross Hospital ( Site 0073), Silver Spring · Miili 7 fagaatti
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- The George Washington Medical facility Associates, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Namoota walitti qabaa jiraSadarkaa 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · Miili 7 fagaatti
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Georgetown Uni Hospital, Washington D.C.
- Medstar Research Institute, Hyattsville · Miili 6 fagaatti
Identifying Patterns in the Breath of Individuals With Breast Cancer
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- GW Comprehensive Breast Center, Washington D.C.
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Namoota walitti qabaa jiraSadarkaa 3
- Georgetown University Medical Center, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
- fi 1 dabalataa
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Namoota walitti qabaa jiraSadarkaa 1
- MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Namoota walitti qabaa jiraSadarkaa 1/2
- Georgetown University, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Namoota walitti qabaa jiraSadarkaa 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · Miili 7 fagaatti
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Namoota walitti qabaa jiraSadarkaa 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- fi 5 dabalataa
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Namoota walitti qabaa jiraSadarkaa 2
- Georgetown University Medical Center, Washington D.C.
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
Namoota walitti qabaa jira
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
Namoota walitti qabaa jira
- Sibley Memorial Hospital, Washington D.C.
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Namoota walitti qabaa jiraSadarkaa 3
- Sibley Memorial Hospital, Washington D.C.
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Namoota walitti qabaa jiraSadarkaa 1/2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Namoota walitti qabaa jira
- Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Namoota walitti qabaa jiraSadarkaa 3
- Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
E-Mindfulness Approaches for Living After Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- fi 2 dabalataa
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
Namoota walitti qabaa jiraSadarkaa 2
- National Institute of Health Clinical Center, Bethesda · Miili 7 fagaatti
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Namoota walitti qabaa jiraSadarkaa 3
- American Oncology Partners, P.A., Bethesda · Miili 7 fagaatti
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Georgetown University Medical Center, Washington D.C.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Namoota walitti qabaa jiraSadarkaa 3
- MedStar Washington Hospital Center, Washington D.C.
- Maryland Oncology Hematology P.A., Silver Spring · Miili 7 fagaatti
- Maryland Oncology Hematology P.A., Bethesda · Miili 7 fagaatti
- fi 1 dabalataa
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Namoota walitti qabaa jiraSadarkaa 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- George Washington University Medical Center, Washington D.C.
- fi 2 dabalataa
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Cancer Support Community Research & Training Institute, Washington D.C.
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Georgetown University, Washington D.C.
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
Namoota walitti qabaa jiraSadarkaa 2
- George Washington-Medical Faculty Associates, Washington D.C.
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
Namoota walitti qabaa jira
- Sibley Memorial Hospital, Washington D.C.
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Holy Cross Hospital - Silver Spring, Silver Spring · Miili 7 fagaatti
- The Center for Cancer and Blood Disorders - Bethesda, Bethesda · Miili 7 fagaatti
Study in Patients With Breast Cancer Leptomeningeal Metastasis
Namoota walitti qabaa jiraQorannoo ilaalaa
- Sibley Memorial Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Silver Spring · Miili 7 fagaatti
- Massive Bio SYNERGY-AI site, Bethesda · Miili 7 fagaatti
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
Namoota walitti qabaa jira
- Georgetown University, Washington D.C.
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Namoota walitti qabaa jiraQorannoo ilaalaa
- Maryland Oncology Hematology, PA, Silver Spring · Miili 7 fagaatti
- Maryland Oncology Hematology - Bethesda, Bethesda · Miili 7 fagaatti
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Namoota walitti qabaa jiraQorannoo ilaalaa
- George Washington University, Washington D.C.
Qorannoo Saree Oljoo magaalota biroo keessatti
- New York City, NYQorannoo 136
- Houston, TXQorannoo 126
- Boston, MAQorannoo 112
- Nashville, TNQorannoo 81
- Los Angeles, CAQorannoo 73
- Edison, NJQorannoo 68
- St. Louis, MOQorannoo 64
- Queens, NYQorannoo 64
- Durham, NCQorannoo 64
- Chicago, ILQorannoo 59
- Philadelphia, PAQorannoo 56
- Dallas, TXQorannoo 55
Qorannoo biroo Washington keessatti
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 55
- Kansara MetastatikiiQorannoo 43
- Dhibee QaraQorannoo 41
- Kansarii ProstateQorannoo 38
- ObesityQorannoo 33
- Kansarii ColorectalQorannoo 29
- Dhibee Onneessaa fi DhiigaQorannoo 28
- Dukkana BladderQorannoo 26
- Leukemia Myeloidii HamaaQorannoo 24
- Kansarii OvariiQorannoo 23
- LymphomaQorannoo 23
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.